Top Health Tech Companies in Manchester (23)
Our vision is to deliver “AI Brains” that closely resemble human brains that perceive, understand and continuously learn. We are achieving our vision through deploying AI capabilities closer to human level intelligence through the use of unlabeled data, unsupervised few-shot learning, knowledge consolidation and sharing. We deliver brain-inspired AI solutions that enable our select customers and partners to maximally exploit...
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 38 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New...
Bupa's Top Stability & Growth Strengths
Strong Revenue Growth: Group results show double‑digit revenue and underlying profit growth in 2024, with customers rising sharply. 2025 materials indicate continued revenue and profit increases alongside a larger customer base, with growth remaining solid even excluding first‑time consolidation effects.
Strong Market Position & Advantage: Independent market analysis places Bupa as the UK PMI leader within a concentrated 'big four', and official statistics show it as the largest fund in Australian private health insurance. Bupa Global is viewed as a tier‑one IPMI provider, and the insurer‑plus‑provider model strengthens competitive positioning across multiple regions.
Market Expansion: Company updates highlight ongoing expansion of clinics, dental centres, hospitals and digital health (Blua), with dozens of new sites opened in 2024 and further additions in 2025. Portfolio moves such as consolidating Niva Bupa in India and adding UK provision assets broaden reach into fast‑growing markets and channels.
We’ve created an ecosystem of patent-protected wearable technology which transforms human data into actionable insights that improve health, wellness, and performance. It’s the secret ingredient to unlocking true human potential
We’re an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and develop groundbreaking products and services that benefit everyone, we are especially passionate about those that advance women’s health and well-being. This allows us to be a company that prospers, grows and empowers women to experience healthier lives. None of this would...
Hologic's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent performance and satisfaction recognition in breast imaging, a dominant position in ThinPrep cervical screening, and a large Panther installed base indicate entrenched category leadership and switching-cost advantages in core women’s health niches.
Healthy Cash Flow: Operating cash flow increased materially in the most recent quarter cited, supporting stability and capacity to fund ongoing operations and investment despite mixed segment performance.
Diversified Revenue Streams: Revenue contributions from Breast Health, Diagnostics, and Surgical—along with recurring assay and service components tied to installed bases—help balance cyclicality in capital equipment and post-pandemic testing normalization.
At Costello Medical, we enjoy building lasting partnerships in the healthcare sector by providing an exceptional service. Our vision is to be a community of the very best people, constantly challenging ourselves to make meaningful and outstanding contributions to improving healthcare. Our experts support the healthcare sector in the analysis, interpretation, and communication of clinical and health economic data; our service...
In November 2011 Dom Raban (one of the Xploro® founders) received the tragic news that his 13 year old daughter had been diagnosed with Ewing’s Sarcoma, a rare bone cancer. She's now 7 years cancer-free but when she was ill she received virtually no prior information about the people she would meet, the environments she would be treated in or the...
Spire Healthcare Group plc is a leading independent healthcare provider in the United Kingdom, operating a network of private hospitals and clinics that offer diagnostics, inpatient, day case, and outpatient care.
Nucleus Global is the largest specialist medical communications company in the world. Built on a reputation of scientific excellence and quality, we are a global leader in delivering world-class, innovative education and medical marketing services to the pharmaceutical and biotechnology industries.
B. Braun is one of the world's leading medical technology companies. With over 65,000 employees, the family-owned company is a true partner, developing smart solutions and setting standards to drive advancements in health care. In 2022, the B. Braun Group generated sales of € 8.5 billion. You want to protect and improve the health of people around the world? Then...
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers,...
STERIS's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue from continuing operations grew 9% in FY2026 with 7% constant-currency organic growth, extending momentum from FY2025. Guidance for FY2027 calls for 7–8% reported revenue growth and 9–11% adjusted EPS growth.
Healthy Cash Flow: Operating cash flow reached about $1.34B and free cash flow was $983M in FY2026, both above the prior year. A new $1B share repurchase authorization underscores capacity to return capital.
Strong Market Position & Advantage: STERIS is widely viewed as a leader across infection prevention and sterilization, often top‑two with Getinge in equipment and co‑leading outsourced sterilization with Sotera. Competitor filings explicitly naming STERIS AST as a primary rival validate its top‑tier standing.
Helios Medical Communications is a full-service, independent, global healthcare communications and strategic consultancy agency. We specialise in delivering high-quality, high-impact bespoke solutions to meet our clients’ needs. Our core services include: · Strategic medical communications consultancy · Medical education · Publications and medical writing · External expert strategy and collaboration · Internal training solutions (MSL and brand) · Meetings ·...
The Adelphi Group provides a wide range of strategic support services and consulting for global pharmaceutical clients. Adelphi is dedicated to the healthcare sector, providing services across strategic marketing, marketing and business intelligence, real-world observational research and disease-specific programmes, health and economic outcomes, market access, pricing and reimbursement, value insight, multi-channel health communications, scientific services, medical education, and strategic product...
At Kooth Digital Health, we create easy to access online mental health services, offering free, safe and anonymous support.
Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better. Blueberry focuses on the research and development...
LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for...
LGC's Top Stability & Growth Strengths
Strong Market Position & Advantage: Holding the UK’s National Measurement Laboratory designation and Government Chemist role, plus leading positions in reference materials, proficiency testing, and agrigenomics/genotyping, reinforces defensible niche leadership. Acquisitions and widespread adoption of technologies like KASP genotyping underscore recognized authority in core segments.
Strong Revenue Growth: Reported revenue increased year over year in FY25, reversing the prior year’s dip. Adjusted EBITDA also rose, indicating improved top-line momentum alongside better operating results.
Future-Ready Strategy: Large-scale site expansions (Toronto, Guildford, Berlin) and integration of recent acquisitions point to capacity build-out and a scale-focused operating model. A new CEO, business-unit consolidation, and an Innovation Hub signal intent to sustain growth through portfolio development and execution.
We are BOLDSCIENCE. We are a scientifically creative global medical communications agency. What exactly does that mean? It means our staff are made up of talented science communicators, artists, and curious disruptors, that collaborate to create impactful communication programs for pharmaceutical clients who need a compelling voice. We know what it takes to create brands, to start new conversations, to...
We work in partnership with the NHS serving more than 5.8 million patients by helping them to see a doctor face-to-face wherever they are at a time and place that suits them on their smartphone, tablet, or laptop. Push Doctor technology assists the NHS in managing demand and easing appointment backlogs, so clinicians can focus and spend time on patients...
Real Chemistry is a global health innovation company with offices across the United States and Europe. We believe that the way to real, transformative change is through the uncommon combination of disciplines, technologies, and our greatest asset – our people. We are currently looking to add to our alchemic mix of more than 1,800 talented professionals.
EPAM (NYSE:EPAM) is a global leader in AI transformation engineering and integrated consulting, serving Forbes Global 2000 companies and ambitious startups. With over thirty years of expertise in custom software, product and platform engineering, EPAM empowers organizations to become AI-Native enterprises, driving measurable value from innovation and digital investments. Recognized by industry benchmarks and leading analysts as a leader in...
EPAM Systems's Top Stability & Growth Strengths
Strong Market Position & Advantage: Analyst and client recognitions position EPAM as a leader in digital engineering and AI-enabled transformation, including multiple IDC MarketScape leadership placements and a Gartner recognition for custom software development. Independent coverage likewise describes the firm as a leading provider in these segments, reinforcing a durable competitive footing.
Resilient & Sustainable Growth: Revenue continues to expand year over year in recent quarters and on a trailing-twelve-month basis, and management still guides to growth for the current year despite a tougher backdrop. The pace has moderated compared with the prior year, but the trajectory remains positive.
Innovation-Driven Growth: The company is leaning into AI-native services and is identified as a leader in AI transformation engineering alongside strengths in data modernization and software engineering. This innovation-led mix is presented as a key engine for future expansion.






















.jpeg)












